Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, and myasthenia gravis are now recruiting.


Reach out for more information about our cell therapy programs & capabilities here in Philadelphia

Strike Up a Conversation

Do you have a question or comment? Please get in touch. We’d love to hear from you via one of the methods below.

2929 Arch Street, Suite 600 Philadelphia, PA, 19104, US

+1 267 759 3100

Email / Link
General Inquiries: contactus@cabalettabio.com
Investors: investors@cabalettabio.com
Whistleblower Reporting: https://irdirect.net/CABA/whistleblower_iframe